Cite
Braga CL, Acquarone M, da C Arona V, et al. Can epigenetics help solve the puzzle between concomitant cardiovascular injury and severity of COVID-19?. J Cardiovasc Pharmacol. 2021;doi: 10.1097/FJC.0000000000001201.
Braga, C. L., Acquarone, M., da C Arona, V., Osório, B. S., Barreto, T. G., Kian, R. M., Pereira, J. P. A. L., de Moraes C da Silva, M., Silva, B. A., de Oliveira, G. M. M., Macedo Rocco, P. R., Silva, P. L., & Alencar, A. K. N. (2021). Can epigenetics help solve the puzzle between concomitant cardiovascular injury and severity of COVID-19?. Journal of cardiovascular pharmacology, . https://doi.org/10.1097/FJC.0000000000001201
Braga, Cássia L, et al. "Can epigenetics help solve the puzzle between concomitant cardiovascular injury and severity of COVID-19?." Journal of cardiovascular pharmacology vol. (2021). doi: https://doi.org/10.1097/FJC.0000000000001201
Braga CL, Acquarone M, da C Arona V, Osório BS, Barreto TG, Kian RM, Pereira JPAL, de Moraes C da Silva M, Silva BA, de Oliveira GMM, Macedo Rocco PR, Silva PL, Alencar AKN. Can epigenetics help solve the puzzle between concomitant cardiovascular injury and severity of COVID-19?. J Cardiovasc Pharmacol. 2021 Dec 10; doi: 10.1097/FJC.0000000000001201. Epub 2021 Dec 10. PMID: 34935698.
Copy
Download .nbib